Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Conditions

Sarcoma 1Recurrence 1Neoplasms 1Gastrointestinal Stromal Tumors 1Death 1Bone Neoplasms 1

Interventions

Cyclophosphamide 155Dexamethasone 141Rituximab 85fludarabine 80Lenalidomide 72Cytarabine 70Bortezomib 65fludarabine phosphate 63Gemcitabine 62venetoclax 55pomalidomide 53Etoposide 53pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Quality Assurance, Health Care × Clear all
NCT07484282 2026-04-03

Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer

National Institutes of Health Clinical Center (CC)

Withdrawn

Death, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡